Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule

K. Belanger, R. Tozer,S. Burdette-Radoux,M. Davis, R. Lohmann,B. Zee,N. Wainman,L. Seymour

EUROPEAN JOURNAL OF CANCER(1999)

引用 1|浏览5
暂无评分
关键词
phase ii study
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要